CYFRA 21-1 as a disease severity marker for autoimmune pulmonary alveolar proteinosis.

Item

http://www.wikidata.org/entity/Q44116949

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

CYFRA 21-1 as a disease severity marker for autoimmune pulmonary alveolar proteinosis.

@en

CYFRA 21-1 as a disease severity marker for autoimmune pulmonary alveolar proteinosis.

@nl

type

Item

label

CYFRA 21-1 as a disease severity marker for autoimmune pulmonary alveolar proteinosis.

@en

CYFRA 21-1 as a disease severity marker for autoimmune pulmonary alveolar proteinosis.

@nl

prefLabel

CYFRA 21-1 as a disease severity marker for autoimmune pulmonary alveolar proteinosis.

@en

CYFRA 21-1 as a disease severity marker for autoimmune pulmonary alveolar proteinosis.

@nl

P1476

CYFRA 21-1 as a disease severity marker for autoimmune pulmonary alveolar proteinosis

@en

P2093

Akiko Matsumuro

http://www.w3.org/2001/XMLSchema#string

Chikatoshi Sugimoto

http://www.w3.org/2001/XMLSchema#string

Keiko Nakao

http://www.w3.org/2001/XMLSchema#string

Koh Nakata

http://www.w3.org/2001/XMLSchema#string

Naoko Takeuchi

http://www.w3.org/2001/XMLSchema#string

Seiji Hayashi

http://www.w3.org/2001/XMLSchema#string

Toru Arai

http://www.w3.org/2001/XMLSchema#string

Yasushi Inoue

http://www.w3.org/2001/XMLSchema#string

Yoshikazu Inoue

http://www.w3.org/2001/XMLSchema#string

P2860

Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.

Granulocyte/macrophage colony-stimulating factor treatment improves alveolar epithelial barrier function in alcoholic rat lung

Partitioning lung and plasma proteins: circulating surfactant proteins as biomarkers of alveolocapillary permeability.

Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis.

Pulmonary alveolar proteinosis: progress in the first 44 years.

Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis.

Transgenic overexpression of granulocyte macrophage-colony stimulating factor in the lung prevents hyperoxic lung injury

Serum neutralizing capacity of GM-CSF reflects disease severity in a patient with pulmonary alveolar proteinosis successfully treated with inhaled GM-CSF.

Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.

Serum KL-6 level as a monitoring marker in a patient with pulmonary alveolar proteinosis.

P304

246-252

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/RESP.12210

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Masaki Hirose

P577

2013-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24251830

http://www.w3.org/2001/XMLSchema#string